Prot #G1T48-01: A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Ascending Doses of G1T48 in Women with Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer

Project: Research project

StatusActive
Effective start/end date7/16/197/16/22

Funding

  • DrugDev Inc. (Prot #G1T48-01)
  • G1 Therapeutics, Inc. (Prot #G1T48-01)